Michael Zelasky, BS

Head of Biostatistics, Statistical Programming and Data Management
Iterum Therapeutics

Disclosure: Iterum Therapeutics (Employee)

Presentation(s):

• LB-1 - Efficacy and Safety of Oral Sulopenem Etzadroxil/Probenecid Versus Oral Ciprofloxacin in the Treatment of Uncomplicated Urinary Tract Infections (uUTI) in Adult Women: Results from the SURE-1 Trial

  Oral Abstract